Project Grant R25DA064339
Award Date 9/15/25
Completion Date 8/31/28
Dollars Obligated $326K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Austin, TX 78712, USA
Similar Awards
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a $397,829 Project Grant to Callentis Consulting Group LLC, a woman-owned small business in Austin, Texas. The grant, awarded on May 1, 2025, supports the development of an artificial intelligence (AI) platform to discover new therapeutics for substance use disorders. The key products and services to be delivered include: 1) Curated training datasets and machine learning...
- This $1,483,186 Project Grant was awarded by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025. The grant recipient, Verisim Life, Inc., is using the funding to develop an AI-driven drug discovery platform to accelerate the development of novel therapeutic agents for stimulant use disorder (STUD), a critical unmet medical need. During the Phase I effort, Verisim Life integrated...
- This $304,215 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports the development and validation of a novel software platform for decentralized clinical trials in substance use disorder (SUD) research. The software will incorporate large language models to address challenges in SUD clinical trials, such as participant diversity, recruitment, and retention. The award recipient, Carina Medical LLC, is a...
- The National Institute on Drug Abuse (NIDA) awarded a $164,000 Project Grant to The Trustees of Princeton University for the development of a "Chemical AI and Data Science Platform for the Identification and Discovery of Novel Psychoactive Substances." The 2-year project, running from August 2025 to July 2027, aims to create a comprehensive database of known novel psychoactive substances (NPS) and leverage artificial intelligence (AI) tools to predict the structure and mass...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) provides $273,987 to develop and enhance the "RtutorAI" platform. RtutorAI is an AI-powered virtual assistant that enables users to analyze large biomedical datasets through natural language interactions, without requiring coding expertise. The project aims to: (1) optimize prompt engineering and upgrade to GPT-4 for improved...
- This federal Project Grant award of $798,828.00 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to discover novel small molecule therapeutics for the safe and effective treatment of opioid use disorder (OUD). The key products and services to be delivered include: The development of an AI platform called M3.AI that will integrate target-based and phenotype-based methodologies to efficiently identify new drug candidates for OUD...
- The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), has awarded a $306,872 Project Grant to Biomotivate LLC to develop and evaluate the PEACE Platform, a novel solution that leverages personalized audiovisual content and machine learning algorithms to help individuals with opioid use disorders (OUDs) build their capacity to manage negative emotions and stressors. The research design involves integrating generative AI, predictive...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $611,254 to fund the "Brains, Minds and Machine Advanced Research Training Course" at the Marine Biological Laboratory (MBL) in Woods Hole, MA. The goal of this in-person course is to cultivate a community of leaders with deep expertise in neuroscience, cognitive science, and computer science to advance the scientific...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $191,700.00 to Cedars-Sinai Medical Center to develop and validate an AI-driven framework to efficiently predict and identify severe opioid adverse drug effects, including persistent use and related post-surgical outcomes, from electronic health record (EHR) data. The project aims to leverage automated machine learning, knowledge graphs, and...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $1,080,885 to the University of Southern California (USC) from September 2024 to September 2027. The funding supports the development of novel neural network models that can capture the nonlinear dynamics of large-scale brain networks and their relationship to behavior. The models will have flexible inference capabilities, enabling real-time,...